Andromeda has partnered with Injective to accelerate the adoption of DeFi applications.

According to ChainCatcher news, Andromeda has announced a strategic partnership with Injective. The two parties will accelerate the adoption of DeFi by combining Andromeda's aOS and Injective's high-speed financial blockchain. Key highlights of the collaboration include seamless cross-chain integration, advanced DeFi applications, asset tokenization management, and simplified segmentation of digital assets.

It is reported that this partnership will enhance cross-chain capabilities and simplify asset management, fully unleashing the potential of the next generation of Web3 applications.